Novo Nordisk said it will approach regulators with the data on the SCD therapy in H2 2026.
The post Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory appeared first on Clinical Trials Arena.
[Sponsored] Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to …
مع اقتراب موسم الحج، لا يقتصر الاستعداد على الجوانب التنظيمية أو تجهيز الحقائب، بل يمتد ليشمل جانبًا صحيًا لا يقل أهمية، خاصة لأصحاب الأمراض المزمنة الذين …
Senate Republicans say the dysfunction in the House is becoming a liability for the broader GOP brand ahead of this year’s midterm elections, warning that if …
The virus that is believed to be responsible for the deaths of three people and the illnesses of three others aboard a cruise ship over the …